Thermal ablation with magnetic resonance–guided focused ultrasound surgery (MRgFUS) is a noninvasive technique for treating fibroids and cancer. New research from UC Davis shows that combining the technique with chemotherapy can allow complete destruction of tumors in mice.
MRgFUS combines an ultrasound beam that heats and destroys tissue with a magnetic resonance imaging to guide the beam and monitor the effects of treatment. The effectiveness of the treatment can be limited by the need to spare normal tissue or critical structures on the tumor margins, as well as the need to eliminate micrometastases.
In a new paper in The Journal of Clinical Investigation, Katherine W. Ferrara, distinguished professor of biomedical engineering at UC Davis, and colleagues report on a strategy that can destroy an entire tumor without thermal destruction of the tumor margin. Her group demonstrated a dramatic increase in the concentration of anti-cancer chemotherapy within several types of MRgFUS thermal ablation-treated tumors.
“MRgFUS is already FDA approved for the treatment of uterine fibroids and palliation of bone metastases. We hope to expand the indication for MRgFUS by supplementing it with chemotherapy,” said first author Andrew Wong, a graduate student with the UC Davis Physician Scientist Training Program.
Ferrara’s previous research has shown that ultrasound-induced mild hyperthermia can enhance the accumulation of tiny nanoparticles carrying anti-cancer drugs, but the accumulation is dependent on the type of tumor. Her group hypothesized that combining thermal ablation and chemotherapy could improve efficacy across multiple types of tumors.
The team used a variety of techniques including combined positron emission tomography/computed tomography (PET-CT), magnetic resonance imaging, autoradiography, and fluorescence imaging to track nanoparticles loaded with the chemotherapy drug doxorubicin in a mouse model of breast cancer.
They found that as the ultrasound damaged the tumor and induced a local immune response, nanoparticles accumulated in the tumor and the local drug concentration increased 50-fold. The high drug concentrations continued over several weeks, increasing total exposure of the tumor to the drug.
Ferrara’s research team found that the enhanced drug accumulation induced by MRgFUS resulted in improved survival and a consistent cure in their preclinical model of breast cancer, even when part of the tumor was left intact.
They also demonstrated that an effective cure could be achieved with a carefully designed protocol involving heat-activated nanoparticles, which, when gently heated by ultrasound, release their chemotherapeutic payload in the vasculature surrounding the tumor.
The Latest on: MRgFUS
via Google News
The Latest on: MRgFUS
- Uterine Fibroids Associated With Infertilityon May 10, 2022 at 5:00 pm
L Barmat is an Intuitive Surgical proctor for gynecologic surgeries. The authors have no other relevant affiliations orfinancial involvement with any organization or entity with a financial ...
- MRI Guided Drug Delivery Market : Advancement In Medical Technology Will Drive the Demand Pieon May 2, 2022 at 5:00 pm
Popular brands of MRI guided drug delivery systems include TULSA-PRO (Profound Medical Corp), NeuroBlate (Monteris), and MRGFUS (Insightec Ltd.). The MRI Induced Drug Delivery Sales study provides ...
- FDA Expands Indication for Insightec’s Uterine Fibroid Systemon April 16, 2022 at 5:00 pm
According to Globes Online, The US Food and Drug Administration has expanded indication for InSightec Ltd’s ExAblate® 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of ...
- The Technology Redefining Surgery: MR-Guided Focused Ultrasoundon March 29, 2022 at 5:00 pm
Looking Ahead: The Impact of MRgFUS on Patients and Physicians MR-guided focused ultrasound devices have been adopted and are being used by physicians in more than 80 leading medical facilities in the ...
- Noninvasive functional neurosurgery using ultrasoundon January 27, 2022 at 3:38 pm
To enable noninvasive treatment of brain tissues with ultrasound, Kullervo Hynynen and colleagues have refined an image-guided technique known as MRI-guided focused ultrasound (MRgFUS), which is ...
- MR-Guided Focused Ultrasound for the Novel and Innovative Management of Osteoarthritic Knee Painon January 27, 2022 at 3:38 pm
This is the first report of clinical application of MRgFUS for knee OA. Real-time monitoring of the sonication area and temperature elevation enabled performance of safe and accurate treatment.
- Ultrasound technology used for first time to treat uncontrollable tremorson June 23, 2021 at 3:16 am
More than £2 million has been raised by the University of Dundee to purchase the Magnetic Resonance-guided Focused Ultrasound (MRgFUS) technology. It uses sound waves to help destroy tissue that ...
- Stereotactic and Functional Neurosurgery Fellowshipon December 18, 2020 at 6:46 am
The 12-month BCM Stereotactic and Functional Fellowship provides an intensive surgical experience in all areas of adult and pediatric functional neurosurgery, combined with collaborative training with ...
- INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Patients with Parkinson's Diseaseon September 3, 2020 at 9:52 am
About INSIGHTEC INSIGHTEC is the world leader and innovator of MR-guided Focused Ultrasound (MRgFUS). The company's non-invasive platforms, Exablate and Exablate Neuro, are proven technology ...
- In Replyon April 30, 2015 at 3:35 pm
The factors determining its suitability for the treatment of fibroids are almost identical with those for MR-guided focused ultrasound surgery (MRgFUS). The success rates and the unincreased ...
via Bing News